MAP3K19
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| mitogen-activated protein kinase kinase kinase 19 | Ensembl:ENSG00000176601 | HGNC:HGNC:26249 | PA142670554 | 2q21.3 |
GO terms in MAP3K19
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0007346 | regulation of mitotic cell cycle |
| BP | IBA | GO:0023014 | signal transduction by protein phosphorylation |
| BP | IBA | GO:0032147 | activation of protein kinase activity |
| CC | IBA | GO:0005737 | cytoplasm |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: MAP3K19
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MAP3K19
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD5 | Tyrphostin AG 1478 | 2 |
| iGMDRD138 | PX 12 | 2 |
| iGMDRD271 | Brefeldin A | 3 |
| iGMDRD513 | BML-259 | 1 |
| iGMDRD294 | Batimastat | 1 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD434 | BMS-536924 | 2 |
| iGMDRD192 | CIL56 | 3 |
| iGMDRD289 | Parthenolide | 5 |
| iGMDRD221 | Tamoxifen | 5 |
| iGMDRD662 | JQ-1 | 3 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD451 | Serdemetan | 2 |
| iGMDRD630 | ML203 | 3 |
| iGMDRD356 | PNU-74654 | 1 |
| iGMDRD268 | Cerulenin | 2 |
| iGMDRD64 | Parbendazole | 3 |
| iGMDRD505 | Pevonedistat | 2 |
| iGMDRD425 | ERASTIN | 1 |
| iGMDRD607 | Ubistatin B | 3 |
| iGMDRD433 | Lexibulin | 1 |
| iGMDRD210 | AC55649 | 2 |
| iGMDRD151 | CHM-1 | 2 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD424 | Tamatinib | 3 |
| iGMDRD560 | MK-2206 | 1 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD193 | Fqi1 | 3 |
| iGMDRD945 | ML214 | 2 |
| iGMDRD123 | Isoevodiamine | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MAP3K19
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.